The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models
2.
How artificial intelligence could significantly improve the prognosis for cancer patients.
3.
Q&A: Why adolescents and young adults with cancer are falling behind
4.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
5.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
1.
Strategic Standards in Hematology for Specialists
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
4.
The Science Behind Imatinib: How It Targets Cancer Cells
5.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation